Six substudies from the semaglutide trials: Identifying mechanisms of benefit and whom to treat

J Am Coll Cardiol. 2024 Aug 22:S0735-1097(24)08250-0. doi: 10.1016/j.jacc.2024.08.038. Online ahead of print.

Author

Neha J Pagidipati¹

Affiliation

¹ Duke Clinical Research Institute, Durham NC. Electronic address: neha.pagidipati@duke.edu.

PMID: 39218241
DOI: 10.1016/j.jacc.2024.08.038

No abstract available

Publication types

Editorial